Related Experiment Video
Updated: Oct 30, 2025

07:47
Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.8K
Comprehensive Transcriptomic Analysis Reveals Prognostic Value of an EMT-Related Gene Signature in Colorectal Cancer
Shaobo Mo1,2, Weixing Dai1,2, Zheng Zhou1,2
1Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
Frontiers in Cell and Developmental Biology
|July 2, 2021
Summary
This study identifies an epithelial-mesenchymal transition (EMT) gene signature crucial for predicting colorectal cancer (CRC) recurrence. This signature aids in stratifying patients by risk, offering potential prognostic and therapeutic insights for CRC.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Lymph node metastasis (LNM) significantly impacts colorectal cancer (CRC) recurrence and patient survival.
- The epithelial-mesenchymal transition (EMT) pathway is implicated in cancer progression and metastasis.
Purpose of the Study:
- To identify and validate an EMT-related gene signature for predicting LNM and prognosis in CRC.
- To explore the functional role of EMT-associated genes in CRC proliferation and metastasis.
- To develop prognostic nomograms for clinical decision-making in CRC.
Main Methods:
- Gene set variation analysis (GSVA) and gene set enrichment analysis (GSEA) were employed.
- An EMT-related gene signature was developed using LIMMA and LASSO Cox regression on a discovery cohort (489 CRC patients).
- Validation was performed on six independent datasets (1,045 CRC patients) with stratification analysis, alongside in vitro and in vivo functional studies.
Main Results:
- The EMT signaling pathway was identified as highly relevant to LNM in CRC.
- The developed EMT-related gene signature accurately stratified CRC patients into high- and low-risk groups.
- Functional analyses suggested that EMT-signature-associated genes play a role in CRC proliferation and metastasis.
Conclusions:
- An EMT-related gene signature holds significant prognostic value for predicting postoperative recurrence in CRC patients.
- This signature serves as a potential prognostic and therapeutic biomarker for CRC.
- Prognostic nomograms integrating the signature and clinical factors can aid in patient management and decision-making.

